| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ATP-dependent chromatin remodeler activity | 4.46e-04 | 37 | 17 | 2 | GO:0140658 | |
| GeneOntologyMolecularFunction | histone binding | 1.37e-03 | 265 | 17 | 3 | GO:0042393 | |
| GeneOntologyBiologicalProcess | saliva secretion | 7.62e-05 | 17 | 16 | 2 | GO:0046541 | |
| GeneOntologyCellularComponent | chromatin | 5.38e-04 | 1480 | 16 | 6 | GO:0000785 | |
| GeneOntologyCellularComponent | synaptic membrane | 8.34e-04 | 583 | 16 | 4 | GO:0097060 | |
| GeneOntologyCellularComponent | presynaptic membrane | 1.13e-03 | 277 | 16 | 3 | GO:0042734 | |
| HumanPheno | Atypical absence seizure | 6.81e-06 | 46 | 5 | 3 | HP:0007270 | |
| HumanPheno | EEG with focal sharp slow waves | 5.99e-05 | 13 | 5 | 2 | HP:0011195 | |
| HumanPheno | EEG with focal epileptiform discharges | 1.17e-04 | 118 | 5 | 3 | HP:0011185 | |
| HumanPheno | Personality disorder | 1.17e-04 | 18 | 5 | 2 | HP:0012075 | |
| HumanPheno | Status epilepticus without prominent motor symptoms | 2.68e-04 | 27 | 5 | 2 | HP:0031475 | |
| HumanPheno | Generalized non-motor (absence) seizure | 3.85e-04 | 176 | 5 | 3 | HP:0002121 | |
| HumanPheno | Non-motor seizure | 5.38e-04 | 197 | 5 | 3 | HP:0033259 | |
| HumanPheno | Status epilepticus | 6.23e-04 | 207 | 5 | 3 | HP:0002133 | |
| HumanPheno | Falls | 6.53e-04 | 42 | 5 | 2 | HP:0002527 | |
| HumanPheno | Generalized-onset motor seizure | 8.28e-04 | 228 | 5 | 3 | HP:0032677 | |
| HumanPheno | Bilateral tonic-clonic seizure with generalized onset | 1.00e-03 | 52 | 5 | 2 | HP:0025190 | |
| HumanPheno | Dialeptic seizure | 1.10e-03 | 251 | 5 | 3 | HP:0011146 | |
| HumanPheno | Myoclonic seizure | 1.25e-03 | 262 | 5 | 3 | HP:0032794 | |
| HumanPheno | Almond-shaped palpebral fissure | 1.29e-03 | 59 | 5 | 2 | HP:0007874 | |
| HumanPheno | EEG with generalized epileptiform discharges | 1.36e-03 | 270 | 5 | 3 | HP:0011198 | |
| HumanPheno | Generalized tonic seizure | 1.52e-03 | 64 | 5 | 2 | HP:0010818 | |
| HumanPheno | Abnormal shape of the palpebral fissure | 1.56e-03 | 65 | 5 | 2 | HP:0200005 | |
| HumanPheno | Multifocal epileptiform discharges | 1.61e-03 | 66 | 5 | 2 | HP:0010841 | |
| HumanPheno | Interictal epileptiform activity | 2.21e-03 | 319 | 5 | 3 | HP:0011182 | |
| HumanPheno | Interictal EEG abnormality | 2.34e-03 | 325 | 5 | 3 | HP:0025373 | |
| MousePheno | increased apoptosis | 3.82e-05 | 1008 | 15 | 7 | MP:0006042 | |
| MousePheno | increased cell death | 4.10e-05 | 1019 | 15 | 7 | MP:0012556 | |
| Domain | DUF4208 | 2.34e-06 | 3 | 17 | 2 | IPR025260 | |
| Domain | DUF4208 | 2.34e-06 | 3 | 17 | 2 | PF13907 | |
| Domain | DUF4208 | 2.34e-06 | 3 | 17 | 2 | SM01176 | |
| Domain | Chromodomain_CS | 1.18e-04 | 18 | 17 | 2 | IPR023779 | |
| Domain | Chromo_domain | 2.13e-04 | 24 | 17 | 2 | IPR023780 | |
| Domain | Chromo | 2.50e-04 | 26 | 17 | 2 | PF00385 | |
| Domain | CHROMO_2 | 2.91e-04 | 28 | 17 | 2 | PS50013 | |
| Domain | CHROMO_1 | 2.91e-04 | 28 | 17 | 2 | PS00598 | |
| Domain | SNF2_N | 3.81e-04 | 32 | 17 | 2 | PF00176 | |
| Domain | SNF2_N | 3.81e-04 | 32 | 17 | 2 | IPR000330 | |
| Domain | Chromodomain-like | 3.81e-04 | 32 | 17 | 2 | IPR016197 | |
| Domain | CHROMO | 4.05e-04 | 33 | 17 | 2 | SM00298 | |
| Domain | Chromo/shadow_dom | 4.05e-04 | 33 | 17 | 2 | IPR000953 | |
| Domain | DNA/RNA_helicase_DEAH_CS | 4.56e-04 | 35 | 17 | 2 | IPR002464 | |
| Domain | DEAH_ATP_HELICASE | 5.38e-04 | 38 | 17 | 2 | PS00690 | |
| Domain | - | 3.96e-03 | 746 | 17 | 4 | 3.40.50.300 | |
| Domain | Helicase_C | 4.18e-03 | 107 | 17 | 2 | PF00271 | |
| Domain | HELICc | 4.18e-03 | 107 | 17 | 2 | SM00490 | |
| Domain | Helicase_C | 4.26e-03 | 108 | 17 | 2 | IPR001650 | |
| Domain | HELICASE_CTER | 4.33e-03 | 109 | 17 | 2 | PS51194 | |
| Domain | HELICASE_ATP_BIND_1 | 4.33e-03 | 109 | 17 | 2 | PS51192 | |
| Domain | DEXDc | 4.33e-03 | 109 | 17 | 2 | SM00487 | |
| Domain | Helicase_ATP-bd | 4.41e-03 | 110 | 17 | 2 | IPR014001 | |
| Domain | P-loop_NTPase | 6.25e-03 | 848 | 17 | 4 | IPR027417 | |
| Domain | ZF_RING_1 | 2.82e-02 | 291 | 17 | 2 | PS00518 | |
| Domain | ZF_RING_2 | 2.95e-02 | 298 | 17 | 2 | PS50089 | |
| Pubmed | CHD1 and CHD2 are positive regulators of HIV-1 gene expression. | 2.25e-07 | 2 | 17 | 2 | 25297984 | |
| Pubmed | CHD1 and SPOP synergistically protect prostate epithelial cells from DNA damage. | 6.74e-07 | 3 | 17 | 2 | 33022763 | |
| Pubmed | 1.35e-06 | 4 | 17 | 2 | 9326634 | ||
| Pubmed | 6.17e-05 | 24 | 17 | 2 | 23920106 | ||
| Pubmed | NANOG-dependent function of TET1 and TET2 in establishment of pluripotency. | 7.84e-05 | 27 | 17 | 2 | 23395962 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | 2.15e-04 | 1203 | 17 | 5 | 29180619 | |
| Pubmed | 2.94e-04 | 52 | 17 | 2 | 20114047 | ||
| Pubmed | Analysis of the DNA sequence and duplication history of human chromosome 15. | 3.41e-04 | 56 | 17 | 2 | 16572171 | |
| Pubmed | 3.74e-04 | 733 | 17 | 4 | 34672954 | ||
| ToppCell | 390C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.47e-05 | 170 | 17 | 3 | a6fa0cab1fa829ec601fe48306b4c43c83425b04 | |
| ToppCell | 390C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.47e-05 | 170 | 17 | 3 | b40255eee45eb18b5a297336d7f3845fd8f8aa3b | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 4.53e-05 | 186 | 17 | 3 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 4.60e-05 | 187 | 17 | 3 | 77886f99c229610abd28c4c370d2c7d1536c9782 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 4.68e-05 | 188 | 17 | 3 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.98e-05 | 192 | 17 | 3 | 11088878043a6ff95ba1970361256a82e434b80a | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 4.98e-05 | 192 | 17 | 3 | 47646d7e4990be85072987f92bf18d52f8da752e | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 5.13e-05 | 194 | 17 | 3 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.21e-05 | 195 | 17 | 3 | 5c86fddd6d0530beecf45ea5ba6b823123847696 | |
| ToppCell | Transverse-(5)_Dendritic_cell-(53)_Lymphoid_DC|Transverse / shred on region, Cell_type, and subtype | 5.37e-05 | 197 | 17 | 3 | 15b87fd3906d7388c271d30d0c64b1bcc490801c | |
| ToppCell | Transverse-Dendritic_cell-Lymphoid_DC|Transverse / Region, Cell class and subclass | 5.37e-05 | 197 | 17 | 3 | a58af0ea82f76f2a7abac1f62629ff20d552fc63 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.45e-05 | 198 | 17 | 3 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.45e-05 | 198 | 17 | 3 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.45e-05 | 198 | 17 | 3 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 5.45e-05 | 198 | 17 | 3 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 5.54e-05 | 199 | 17 | 3 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Tracheal|World / Cell types per location group and 10X technology with lineage, and cell group designations | 5.62e-05 | 200 | 17 | 3 | 682960e28542a3d6c119047cd0131941932cfdea | |
| ToppCell | Biopsy_Control_(H.)-Mesenchymal-PLIN2+_Fibroblasts|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 5.62e-05 | 200 | 17 | 3 | cdaf462b1db29dab61038eeab5ddd3eef3386763 | |
| ToppCell | (6)_Macrophage-(61)_LYVE1_Macrophage|(6)_Macrophage / shred on Cell_type and subtype | 6.25e-04 | 98 | 17 | 2 | 30a9a2abd0487e818628db589d31f630ca4d894b | |
| ToppCell | (09)_Ionocytes-(3)_72hpi|(09)_Ionocytes / shred by cell type and Timepoint | 7.86e-04 | 110 | 17 | 2 | fce7d5a0617fc664b657f5bb9abb290e7cc234cb | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Tubular-5|TCGA-Stomach / Sample_Type by Project: Shred V9 | 9.50e-04 | 121 | 17 | 2 | 392700c5032b83d4d4e191fea9bcd170e4567b9d | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Ductal_and_Metaplastic_Carcinoma|TCGA-Breast / Sample_Type by Project: Shred V9 | 9.81e-04 | 123 | 17 | 2 | 51e49a64fbbf77e2ee21f45fd515d43282b11516 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Ductal_and_Metaplastic_Carcinoma-4|TCGA-Breast / Sample_Type by Project: Shred V9 | 9.81e-04 | 123 | 17 | 2 | 11802979943a9205f10facda322fc220d4bf7133 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic-Neutrophil-Neu_c2-CXCR4(low)|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.13e-03 | 132 | 17 | 2 | a1fda8c5287168c4f159203ed27cadfb4ce1b131 | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Dendritic_cells-Monocytes-Macrophages|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.38e-03 | 146 | 17 | 2 | b76110b159acd27a2c8d6a9f98336608ace1ec12 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Lect1_Oxtr|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.43e-03 | 149 | 17 | 2 | 10ffd0051fb027bbebc662ca602c80d89bbf99c6 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_PP_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-03 | 154 | 17 | 2 | 2d98bb7a784fc3215e0d4a1670d662e5df4716c3 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_PP_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.53e-03 | 154 | 17 | 2 | 0dec222101530f1727184dbb7c03969d3884f111 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4/8-lo-Trm_Tgd|Liver / Manually curated celltypes from each tissue | 1.53e-03 | 154 | 17 | 2 | c6308074468235c88ef4ea43ab155d9f86cbf261 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell_prolif|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.55e-03 | 155 | 17 | 2 | 5d157478669b609e1f0f0a75afd0112571fc2c46 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.55e-03 | 155 | 17 | 2 | 969fc4c98a96bf2f436e8e63d4deb2183ef3b864 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes-Non-classical_monocytes_L.1.2.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.55e-03 | 155 | 17 | 2 | 77ae0b8d30bc3db4a73fd5340f99691a73d2684f | |
| ToppCell | PND01-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_prolif|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.57e-03 | 156 | 17 | 2 | 895927228c93cd090303984c5be6ebfb59ed6f3a | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 1.57e-03 | 156 | 17 | 2 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Radial_glial-gliogenic/outer_RGCs_and_astrocytes|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 1.59e-03 | 157 | 17 | 2 | 2c1219ee19a6246a3b9f5c2c1a37f26ea934a822 | |
| ToppCell | facs-Lung-24m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l15|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.63e-03 | 159 | 17 | 2 | 999f30c7273ed77b34537621bcfcc7fc30121138 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell_prolif|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.65e-03 | 160 | 17 | 2 | 830e3ef8c9708d25872c3052a0b2682fa9372111 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Fibroblasts-MatrixFB_->_Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.65e-03 | 160 | 17 | 2 | 778faada072e3abfa76a9a06fd4885fb63de7902 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Cortical_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.67e-03 | 161 | 17 | 2 | 4bb7bae54ba3bdf46b525c01f5ad3db8e49819cb | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Late_airway_SMC|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.71e-03 | 163 | 17 | 2 | 1e8730d75cccf7292010683ab4e81a69d8e3bfa9 | |
| ToppCell | TCGA-Testes-Primary_Tumor-Testicular_Germ_Cell_Tumor-Seminoma-_NOS|TCGA-Testes / Sample_Type by Project: Shred V9 | 1.71e-03 | 163 | 17 | 2 | 67551fefe22bd5b8178fa248fed2a6c17b19fb0f | |
| ToppCell | TCGA-Testes-Primary_Tumor-Testicular_Germ_Cell_Tumor-Seminoma-_NOS-5|TCGA-Testes / Sample_Type by Project: Shred V9 | 1.71e-03 | 163 | 17 | 2 | 80bc3732afd8501938753120b8403098c7c5e928 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.73e-03 | 164 | 17 | 2 | d167c7a987b9b35d1e7725c803df4f9cd5380e47 | |
| ToppCell | control-Epithelial-Ionocyte|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.75e-03 | 165 | 17 | 2 | 5cfba9a46bd8ceeca74a6493057b4d38af6b06fe | |
| ToppCell | LV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 1.75e-03 | 165 | 17 | 2 | f37fd95adc95d7753cf6e55ae819976513c7ec77 | |
| ToppCell | LV-16._Neuronal|World / Chamber and Cluster_Paper | 1.75e-03 | 165 | 17 | 2 | 6ed52cb756d21addf46c7f6c457458b01339fe04 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.77e-03 | 166 | 17 | 2 | d373f1092e85eeb317a7406032b259f11e6adbe0 | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.77e-03 | 166 | 17 | 2 | f453a1d545d59003d98485ac31e85e6cf451817c | |
| ToppCell | NS-control-d_0-4-Epithelial-Ionocyte|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.77e-03 | 166 | 17 | 2 | 6d9fb239f69ba519844f593c00d515e1aac4ff50 | |
| ToppCell | severe-CD4+_T_naive|severe / disease stage, cell group and cell class | 1.80e-03 | 167 | 17 | 2 | 02a8215fca59c357c1cdaa5738849eacf98c0bcc | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT2-AT2_prolif|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.82e-03 | 168 | 17 | 2 | 08f6e171a1ea5cf65149744296d0fcd6c7b9684e | |
| ToppCell | PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.82e-03 | 168 | 17 | 2 | c3d2d573f21350a4a674faff30b06ff644d00ac3 | |
| ToppCell | control-Epithelial-Ionocyte|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.82e-03 | 168 | 17 | 2 | 327b02f19f4a8607c033203824fdc60a1254331f | |
| ToppCell | COVID-19-Heart-Neuronal|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.82e-03 | 168 | 17 | 2 | 88c2c574f428c2502b5fe099bd73b0758f668ef6 | |
| ToppCell | 343B-Myeloid-Dendritic-pDC|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.84e-03 | 169 | 17 | 2 | 632aa3ab39ec87bafcefec6cddf71129a054d3b0 | |
| ToppCell | Control-T/NK_proliferative|World / Disease group and Cell class | 1.84e-03 | 169 | 17 | 2 | fca735cbb55fce4d32dc6632a39acea1d16b87ab | |
| ToppCell | LV-16._Neuronal|LV / Chamber and Cluster_Paper | 1.84e-03 | 169 | 17 | 2 | a8fc8ab0f0757e939e213efb61c03cfe390bf7d2 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Ptprt_Pkp2|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.86e-03 | 170 | 17 | 2 | 14aa86a4f526ed6986afcb28c49225522055550c | |
| ToppCell | 5'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-elicited_macrophage-Monocyte-derived_macrophage-Monocyte-derived_macrophage_L.1.2.5.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.88e-03 | 171 | 17 | 2 | 5e93c76ee60f9d0590ebb140812653a5e1369417 | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 1.88e-03 | 171 | 17 | 2 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.88e-03 | 171 | 17 | 2 | fe0665c5ca01b0b2cc8f20d64587f0847c3d215c | |
| ToppCell | LV-13._Vascular_Smooth_Muscle|LV / Chamber and Cluster_Paper | 1.88e-03 | 171 | 17 | 2 | e99ecae66530d1ae09330cee408c8f3950b87e67 | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Dendritic-migDC|lymph-node_spleen / Manually curated celltypes from each tissue | 1.90e-03 | 172 | 17 | 2 | 1b24bed3cd8e3fa463c5e7cefdf9e99e639e2f84 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.90e-03 | 172 | 17 | 2 | e37c0b5b547a7345179ab258dd2141fec7064c17 | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_10|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.92e-03 | 173 | 17 | 2 | 09a13407a41ff2cba82fc417b72bf9a24ce6c42e | |
| ToppCell | PBMC-Control-Myeloid-cDC-cDC-cDC_10|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.92e-03 | 173 | 17 | 2 | bfec038a6783f166240da4861e100643c6ea80a5 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell-Distal_Convoluted_Tubule_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.92e-03 | 173 | 17 | 2 | 0c74bdb40e635d906fd180412c23bf7fed61621e | |
| ToppCell | Control-Myeloid-MoAM2,_CCL18|Control / Condition, Lineage and Cell class | 1.95e-03 | 174 | 17 | 2 | 4c64ff5666812fb4efa440ba4faeca51d916d68e | |
| ToppCell | RSV-Healthy-2|RSV / Virus stimulation, Condition and Cluster | 1.97e-03 | 175 | 17 | 2 | 0e97189585b7afaf3bd622c3ef10c86412393829 | |
| ToppCell | RSV-Healthy-2|Healthy / Virus stimulation, Condition and Cluster | 1.97e-03 | 175 | 17 | 2 | c47440c0b0513e67fe13b85f10dd8a8d42d0e9a3 | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Ionocyte|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.97e-03 | 175 | 17 | 2 | a1e0a15c69211d6db2edeb101476f0f6e08b90c8 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.97e-03 | 175 | 17 | 2 | fd8b5b756f3df4a04938785f3d9edbb6f1cd20f6 | |
| ToppCell | 368C-Epithelial_cells-Epithelial-J_(AT1-AT2_progenitors)|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.97e-03 | 175 | 17 | 2 | 36c140540497bbe1c5f08fac2d94f08cac18fabb | |
| ToppCell | 5'-Adult-LymphNode-Hematopoietic-Myeloid-Mast_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.99e-03 | 176 | 17 | 2 | 0d203682c372411ba64e97a8eae6c4788e8b6ecf | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.99e-03 | 176 | 17 | 2 | a8875b4ba4abf6625cdeb67bf544ce1573c59060 | |
| ToppCell | Dendritic_Cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 2.01e-03 | 177 | 17 | 2 | d2cd081bdda0eba9f6f6473c4d3939e4bee3440e | |
| ToppCell | Control-Myeloid-MoAM2,_CCL18|Myeloid / Condition, Lineage and Cell class | 2.01e-03 | 177 | 17 | 2 | 470f54fe2b21c7350ea471e02039461a3808f700 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-Ionocyte|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.01e-03 | 177 | 17 | 2 | 99500aed584f793aaf308f8afbf5d1c6a9b4ee55 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_goblet_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.01e-03 | 177 | 17 | 2 | a4c001a8e44142babf9f24dfe6f7b73a70b11b16 | |
| ToppCell | facs-Marrow-Granulocytes-24m-Hematologic-MPP_Fraction_B|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.01e-03 | 177 | 17 | 2 | 4a697866ed542d3201714234cee03451adf1dcc9 | |
| ToppCell | droplet-Marrow-BM-30m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.01e-03 | 177 | 17 | 2 | d1af0cb4b1fb03f04cff5add85e29be8fb8f4dcb | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_goblet_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.01e-03 | 177 | 17 | 2 | 363e07b0f347f3716d530a28ead854b98e27d37c | |
| ToppCell | droplet-Marrow-BM-30m-Hematologic-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.01e-03 | 177 | 17 | 2 | 650095a17e1a39caea74a6e89646565b9332af5d | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.04e-03 | 178 | 17 | 2 | 09475e522dc1b8cf9ff1c25de5d1e3082b162948 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.04e-03 | 178 | 17 | 2 | 35de8f791b0e78a6caf52ff095f05e204a59e828 | |
| ToppCell | 3'-Distal_airway-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.04e-03 | 178 | 17 | 2 | 000d25f3f13cc76cf39c46c312c6fafc2ea4f368 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.06e-03 | 179 | 17 | 2 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | COVID-19-Heart-VSMC|Heart / Disease (COVID-19 only), tissue and cell type | 2.06e-03 | 179 | 17 | 2 | a69ad6912b5c10bb9f9d800f724c792341e9bab1 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-03 | 180 | 17 | 2 | 3d54cc767e25d91ed2203d8a03e5bf5e15f21699 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.08e-03 | 180 | 17 | 2 | 9b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.08e-03 | 180 | 17 | 2 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-03 | 180 | 17 | 2 | f6a2208960d0df1500c974cc44c3c054cd7475a9 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Neuronal-Granular_Neuron_CB_Gabra6|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-03 | 180 | 17 | 2 | d76349ecef7c5878bf215e946f032264161eb61b | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.10e-03 | 181 | 17 | 2 | 9e7d0f1afb8d9bc5a209ddb5314df3a25a0274d9 | |
| ToppCell | facs-Marrow-T-cells-3m-Hematologic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-03 | 181 | 17 | 2 | 57f0cc749ae8b6a3d77e2af31f9a6e4739c57049 | |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-collecting_duct_principal_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-03 | 181 | 17 | 2 | 7af469f5bcb9b1ab3f35b2758bf2afb87e8eba57 | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Dendritic-migDC|lymph-node_spleen / Manually curated celltypes from each tissue | 2.10e-03 | 181 | 17 | 2 | 94680f8dbdf22d83801abc0819417751d363fb12 | |
| ToppCell | facs-Marrow-T-cells-3m-Hematologic-hematopoietic_stem_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-03 | 181 | 17 | 2 | d01b35cc2fc57991a35be6a06cb7351fbabd9a11 | |
| ToppCell | droplet-Spleen-nan-18m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.13e-03 | 182 | 17 | 2 | eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.13e-03 | 182 | 17 | 2 | a8cc56f32efe180e8fb5d69dbe606a794b3db700 | |
| Disease | Lennox-Gastaut syndrome | 4.13e-06 | 6 | 16 | 2 | C0238111 | |
| Disease | Metabolic Bone Disorder | 2.50e-05 | 14 | 16 | 2 | C0005944 | |
| Disease | Osteopenia | 2.88e-05 | 15 | 16 | 2 | C0029453 | |
| Disease | Epileptic encephalopathy | 1.19e-04 | 30 | 16 | 2 | C0543888 | |
| Disease | prostate cancer (implicated_via_orthology) | 1.44e-04 | 33 | 16 | 2 | DOID:10283 (implicated_via_orthology) | |
| Disease | susceptibility to mumps measurement | 7.48e-04 | 75 | 16 | 2 | EFO_0008404 | |
| Disease | Epilepsy, Cryptogenic | 8.93e-04 | 82 | 16 | 2 | C0086237 | |
| Disease | Awakening Epilepsy | 8.93e-04 | 82 | 16 | 2 | C0751111 | |
| Disease | Aura | 8.93e-04 | 82 | 16 | 2 | C0236018 | |
| Disease | Autism Spectrum Disorders | 9.59e-04 | 85 | 16 | 2 | C1510586 | |
| Disease | Uterine leiomyoma | 1.10e-03 | 91 | 16 | 2 | HP_0000131 | |
| Disease | Neurodevelopmental Disorders | 1.15e-03 | 93 | 16 | 2 | C1535926 | |
| Disease | Epilepsy | 1.57e-03 | 109 | 16 | 2 | C0014544 | |
| Disease | lung disease severity measurement | 1.83e-03 | 118 | 16 | 2 | EFO_0007744 | |
| Disease | Papillary Renal Cell Carcinoma | 2.15e-03 | 128 | 16 | 2 | C1306837 | |
| Disease | Renal Cell Carcinoma | 2.15e-03 | 128 | 16 | 2 | C0007134 | |
| Disease | Sarcomatoid Renal Cell Carcinoma | 2.15e-03 | 128 | 16 | 2 | C1266043 | |
| Disease | Chromophobe Renal Cell Carcinoma | 2.15e-03 | 128 | 16 | 2 | C1266042 | |
| Disease | Collecting Duct Carcinoma of the Kidney | 2.15e-03 | 128 | 16 | 2 | C1266044 | |
| Disease | Conventional (Clear Cell) Renal Cell Carcinoma | 2.86e-03 | 148 | 16 | 2 | C0279702 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 3.02e-03 | 152 | 16 | 2 | DOID:0060041 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| CMELKCGKKRMRKDP | 1216 | Q8N139 | |
| KMLLLCQCDKKKRRK | 556 | P20309 | |
| ICKERMRPVKAALKQ | 1416 | O14646 | |
| DPKRIKKCGCKRPKM | 686 | Q12791 | |
| VKLRCPCKRIKKELQ | 796 | Q6ZNB6 | |
| QVKKIREPCLKCVDM | 416 | Q05193 | |
| ICKERMRPVKKALKQ | 1471 | O14647 | |
| CPRMKRKIEREIKCS | 251 | Q8WUM9 | |
| KKMKKRICLVLDCLC | 131 | Q8N2I9 | |
| LRLCCKKLKIFAMPM | 206 | P78395 | |
| MKRKIECPICRKDIK | 431 | O76064 | |
| RFCEMLIKRPCKVKT | 136 | Q8WV92 | |
| EPCVMGERKIFKKRK | 711 | Q9UPU3 | |
| PTLEKKKRKRCGVCE | 581 | Q8NFU7 | |
| RCPLKDPKELKKMKR | 381 | Q6P3X8 | |
| SLERKCMEKEKCKKP | 626 | O15014 | |
| CKKTKIKKTCRRIIP | 81 | Q9H967 |